RecruitingNCT06276309

Protein Molecular Characteristics and Prognosis of Cervical Neuroendocrine Tumors

Sponsor

Fujian Maternity and Child Health Hospital

Enrollment

300 participants

Start Date

Feb 1, 2024

Study Type

OBSERVATIONAL

Conditions

Cervical Cancer Neuroendocrine Neoplasm Women China Cervical Lesion

Summary

The clinical diagnosis and treatment data of 300 cases of cervical neuroendocrine tumors were collected, including age, preoperative biopsy pathology results, postoperative histopathological results, TCT results, and colposcopy biopsy pathology results. At the same time, paraffin tissue specimens (remaining specimens after pathological diagnosis) from 100 cases of cervical neuroendocrine tumors from multiple centers across the country were collected to establish a cervical neuroendocrine tumor data follow-up database. Protein concentration and omics analysis were performed on the data results, to evaluate the molecular characteristics and prognosis of cervical neuroendocrine tumor proteins, and to preliminarily explore its clinical application value.

Eligibility

Sex: FEMALE

Plain Language Summary

Simplified for easier understanding

This is an observational study examining protein patterns in tissue samples from patients with a rare and aggressive type of cervical cancer called cervical neuroendocrine carcinoma, with the goal of identifying markers that predict outcomes and potentially guide future treatments. **You may be eligible if...** - You have been diagnosed with cervical neuroendocrine carcinoma confirmed by pathology - Your clinical records are complete and available **You may NOT be eligible if...** - You are not being treated at the participating hospital - Your follow-up data is missing or your survival information cannot be obtained - You decline to participate - Your tissue sample quality is not sufficient for protein analysis Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.